Pediatrix Medical Group (MD) Appoints Kurt D. Newman to Board

Pediatrix Medical Group, Inc. (NYSE:MD) is one of the top 10 medical AI companies to buy according to analysts. On July 1, the company confirmed the appointment of Dr. Kurt D. Newman to its Board of Directors.

Pediatrix Medical Group (MD) Appoints Kurt D. Newman to Board

He joins the Board as an independent director, having previously served as President and Chief Executive Officer of Children’s National Hospital in Washington. Consequently, his deep understanding and experience in patient needs, clinical practices, and the evolving healthcare landscape will be a valuable addition to Pediatrix Medical management.

“The physician voice is central to patient-centered decision making,” Dr. Newman said in the statement. “I look forward to contributing my experience to strengthen collaboration between physicians, other clinicians, executive leadership and the board.”

Pediatrix Medical Group, Inc. (NYSE:MD) provides specialized healthcare services for women, babies, and children, operating as a national multispecialty group. It utilizes AI in prenatal care through a partnership with Sonio, specifically integrating Sonio’s AI-powered platform for ultrasound workflow and practice management. This technology aims to streamline ultrasound processes, enhance quality assurance, and improve both patient and provider experiences.

While we acknowledge the potential of MD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Farmland and Agriculture Stocks to Buy According to Billionaires and 10 Best Stocks to Buy Amid Gold Rally.

Disclosure: None. This article is originally published at Insider Monkey.